In NSCLC, interaction of CD161 expressing tumor infiltrating CD4+ and CD8+ T cells with LLT1-expressing germinal center B cells within tumor microenvironment tertiary lymphoid structures resulted in improved survival (73). This evidence concerns the gene KLRB1 and neoplasm.